These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20157583)

  • 1. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential.
    Demidenko ZN; Blagosklonny MV
    Aging (Albany NY); 2009 Dec; 1(12):1008-16. PubMed ID: 20157583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin decelerates cellular senescence.
    Demidenko ZN; Zubova SG; Bukreeva EI; Pospelov VA; Pospelova TV; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1888-95. PubMed ID: 19471117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin, proliferation and geroconversion to senescence.
    Blagosklonny MV
    Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth stimulation leads to cellular senescence when the cell cycle is blocked.
    Demidenko ZN; Blagosklonny MV
    Cell Cycle; 2008 Nov; 7(21):3355-61. PubMed ID: 18948731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
    Leontieva OV; Demidenko ZN; Blagosklonny MV
    Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin.
    Leontieva OV; Demidenko ZN; Gudkov AV; Blagosklonny MV
    PLoS One; 2011; 6(10):e26126. PubMed ID: 22022534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21(Waf1) is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate.
    Romanov VS; Abramova MV; Svetlikova SB; Bykova TV; Zubova SG; Aksenov ND; Fornace AJ; Pospelova TV; Pospelov VA
    Cell Cycle; 2010 Oct; 9(19):3945-55. PubMed ID: 20935470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence.
    Demidenko ZN; Shtutman M; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1896-900. PubMed ID: 19478560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical suppression of cellular senescence by p53.
    Demidenko ZN; Korotchkina LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9660-4. PubMed ID: 20457898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
    Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
    Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
    Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.
    Leontieva OV; Blagosklonny MV
    Aging (Albany NY); 2010 Dec; 2(12):924-35. PubMed ID: 21212465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gerosuppression by pan-mTOR inhibitors.
    Leontieva OV; Blagosklonny MV
    Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.
    Demidenko ZN; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1901-4. PubMed ID: 19471118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The power of chemotherapeutic engineering: arresting cell cycle and suppressing senescence to protect from mitotic inhibitors.
    Blagosklonny MV
    Cell Cycle; 2011 Jul; 10(14):2295-8. PubMed ID: 21715978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudo-DNA damage response in senescent cells.
    Pospelova TV; Demidenko ZN; Bukreeva EI; Pospelov VA; Gudkov AV; Blagosklonny MV
    Cell Cycle; 2009 Dec; 8(24):4112-8. PubMed ID: 19946210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration.
    Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1883-7. PubMed ID: 19448395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16.
    Sung JY; Lee KY; Kim JR; Choi HC
    Exp Gerontol; 2018 Aug; 109():51-58. PubMed ID: 28797827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
    Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
    Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107.
    Khor ES; Wong PF
    Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.